Blood Cancer Awareness Month
Jonathan Dickinson
Chief Executive Officer and Chairman of the Board at Innate Pharma Talks about #oncology, #hematology, #IAI, #rarediseases and #leadership
Throughout the month of September, communities across the world unite to recognize #BloodCancerAwarenessMonth.
Cancer is profoundly personal. Like many others, I’ve experienced great loss because of cancer. When my mother died of myeloma, her loss motivated me to search for ways to cure this particular type of blood cancer.?
But I am not alone on this journey. When our European team lost our first Italian General Manager to multiple myeloma, his passing reinforced our collective commitment to #SolveOnForBloodCancer.?
At @Incyte , we are striving to #SolveOn every day, partnering with patient groups and community members to increase awareness around the impact of blood cancer on those living with this condition, their loved ones, and caregivers.
Some of the initiatives we’re particularly proud of include our partnership with @The Max Foundation , assisting people who are unable to access cancer treatment, and the recent launch of the European “Living with DLBCL Toolkit”. Developed in partnership with @Lymphoma Coalition and European advocacy organizations, this toolkit is designed to support patients with diffuse large B-cell lymphoma (DLBCL), helping them navigate their journey with DLBCL.
While blood cancer treatment has seen significant advancements over the years, finding ways to improve patient outcomes and quality of life should remain a shared priority. As we observe Blood Cancer Awareness Month, I encourage you to raise awareness of the different types of blood cancer, listen to the lived experiences of the community and amplify their voices.
?
Pharma D - Partner in Life Sciences. Biotech-Pharmaceutical Executive Global Commercial Leader. Multiple launch experience, Go-to Market Strategy , Ability to drive growth. lnnovative and Biosimilars
2 个月Thanks for sharing Jonathan Dickinson